SOX2 and ovarian cancer: We have previously shown that SOX2 is a marker of chemoresistance and recurrence in ovarian cancer (26); thus, we next sought to characterize changes in SOX2, OCT4, and NANOG expression in ovarian cancer cells indirectly co-cultured with differentially polarized macrophage populations (Fig. 1A).